The House Energy and Commerce Health Subcommittee on June 14 plans to consider legislation to reauthorize the Prescription Drug User Fee Act and address FDA oversight of medication safety, CQ HealthBeat reports. In a memo, subcommittee Chair Frank Pallone (D-N.J.) said that the bill would increase the annual user fees paid to FDA by pharmaceutical companies to $392. [click link for full article]
More...